Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab

Despite the limited sample size, fT3/fT4 ratio appears to be a promising and accessible biomarker for identifying muscle wasting, which may be linked to diminished treatment response and shorter survival in patients with NSCLC.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-08-27
DOI
https://doi.org/10.3389/fonc.2025.1635321
Citations
2
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab

Ilaria Trestini, Sara Pilotto, Alessandra Dodi, Michèle Milella et al.
2 citations
Frontiers in Oncology
Nutrition and Health in Aging
2.33
article

Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab

Ilaria Trestini, Sara Pilotto, Alessandra Dodi, Michèle Milella, Emilio Bria, Ilaria Mariangela Scaglione, Fotios Loupakis, Maria Cristina Mele, Luca Pasqualin, Marco Cintoni, Isabella Sperduti, Lorenzo Belluomini, Daniela Tregnago, Alice Avancini, Marco Sposito, Jessica Insolda, Serena Eccher, Alessio Stefani, Marcello Tiseo, Linda Confortini
article en
2 citations

Abstract

Despite the limited sample size, fT3/fT4 ratio appears to be a promising and accessible biomarker for identifying muscle wasting, which may be linked to diminished treatment response and shorter survival in patients with NSCLC.

Frontiers in OncologyVol. 15
University of Verona (IT), University of Parma (IT), Agostino Gemelli University Polyclinic (IT), Azienda Sanitaria Locale Viterbo (IT), University Hospitals Parma Medical Center (US), National Cancer Institute (MY)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro, Università Cattolica del Sacro Cuore, Daiichi Sankyo Europe
Openalex Percentile: Top 11%
Nutrition and Health in Aging
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.